Delivery Order SPE2DB24D1201-SPE2DB26FJADR
- Not listed
- The Defense Logistics Agency awarded a $24,730.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Taltz 80 mg/ml autoinjector. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 18, 2025, and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Taltz 80 mg/ml autoinjector at a ceiling value of $3,564.93. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Taltz is a biologic medication...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,753.04 to AmerisourceBergen Drug Corp on June 4, 2025, for TALTZ 80 mg/ml autoinjector units. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of this pharmaceutical product through the federal procurement process. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 5, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $76,320.98 to AmerisourceBergen Drug Corp for Taltz 80 mg/ml autoinjector on April 23, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 24, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $31,434.96 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/ml autoinjector on August 15, 2025, with a ceiling value of $3,524.56. This is a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Taltz is a biologic medication used to...
- The Defense Logistics Agency awarded a delivery order valued at $15,965.18 to AmerisourceBergen Drug Corp for Taltz 80 mg/ml auto-injector two-packs on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Taltz is a biologic medication used to treat inflammatory conditions, and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $17,581.86 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Taltz 80 mg/ml auto-injector medication. This firm fixed-price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Taltz 80 mg/ml autoinjector medication with a ceiling value of $17,030.96. This firm fixed-price delivery order, which is set to conclude on August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB26FJADRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,660.31 to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/mL autoinjector on October 15, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under an existing indefinite delivery contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical support vehicle enables the contractor to supply a broad range of medications, medical supplies, and specialty pharmaceuticals to military and veteran healthcare systems globally. Taltz, a biologic immunosuppressant typically used for autoimmune conditions, reflects the specialized pharmaceutical products that DLA procures to support Defense Health Agency medical operations and broader federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/15/25 |